← All indications
Vaginal Neoplasms
Tumors or cancer of the VAGINA.
Drugs by status
Phase 4 trials (1)
Phase 3 trials (4)
Phase 2 trials (41)
- ino-3112
- metformin
- fluorothymidine
- atezolizumab
- certolizumab pegol
- doxorubicin
- durvalumab
- e6 tcr
- e7 tcr transduced pbl cells
- entinostat
- gemcitabine
- paclitaxel
- aldesleukin
- imiquimod
- nivolumab
- pembrolizumab
- lenvatinib
- fondaparinux sodium
- ipilimumab
- interleukin-12
- cyclosporine
- mycophenolate
- cyclophosphamide
- bevacizumab
- allogeneic lymphocytes
- triapine
- dostarlimab
- young tumor infiltrating lymphocytes
- v505
- bupropion
- +11 more
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (17)
- Millennium Pharmaceuticals
- AstraZeneca
- Merck Serono
- Genentech
- Inovio Pharmaceuticals
- National Institutes of Health (NIH)
- Brown University
- Case Western Reserve University
- Cornell University
- Harvard University
- University of Washington
- Gynecologic Oncology Group
- NRG Oncology
- University of Calgary
- University of Minnesota
- Lowell General Hospital
- Saint Anne's Hospital
Organization Involved with Phase 1 Indications (4)